AltheaDx (United States)

Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility

Paul Bradley, Michael Shiekh, Vishaal Mehra et al. · Journal of Psychiatric Research · 2017 · 213 citations · Full text

Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3

Kenneth W. Foreman, Mark A. Brown, Frances Park et al. · PLoS ONE · 2011 · 120 citations · Full text

Exploring Molecular Pathways of Triple-Negative Breast Cancer

Valeria Ossovskaya, Y. Wang, Adam Budoff et al. · Genes & Cancer · 2011 · 91 citations · Full text

Breast Oncology, Engineering, Cancer Biology +19

Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings

Alejandra Maciel, Ali Cullors, Andrew A. Lukowiak et al. · Neuropsychiatric Disease and Treatment · 2018 · 54 citations · Full text

Cost Savings, Psychotropic Medication, Pharmacotherapy +17

CYP2D6 copy number distribution in the US population

Michelle Beoris, Jean Amos Wilson, Jorge Garcés et al. · Pharmacogenetics and Genomics · 2015 · 53 citations · Full text